Lignans and Human Health

REFERENCES

• World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a Global Perspective. American Institute for Cancer Research, Washington 1997
   Google Scholar
• Adlercreutz H, Fotsis T, Heikkinen R, Dwyer J T, Woods M, Goldin B R, Gorbach S L. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 1982; 2: 1295–1299
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the “fiber hypothesis.”. Gastroenterology 1984; 86: 761–764
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 50: 3–23, (Suppl 201)
   Web of Science ®Google Scholar
• Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T, Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093–1100
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997; 29: 95–120
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis. Proc Soc Exp Biol Med 1998; 217: 241–246
   PubMed Web of Science ®Google Scholar
• Cassidy A, Hanley B, Lamuela-Raventos R M. Isoflavones, lignans and stilbenes—origins, metabolism and potential importance to human health. J Sci Food Agric 2000; 80: 1044–1062
   Web of Science ®Google Scholar
• Wang L Q. Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B 2002; 777: 289–309
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Epidemiology of phytoestrogens. Baillière's Clin Endocrinol Metab 1998; 12: 605–624
   PubMed Web of Science ®Google Scholar
• Penalvo J L, Heinonen S M, Aura A M, Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. J Nutr 2005; 135: 1056–1062
   PubMed Web of Science ®Google Scholar
• Begum A N, Nicolle C, Mila I, Lapierre C, Nagano K, Fukushima K, Heinonen S M, Adlercreutz H, Remesy C, Scalbert A. Dietary lignins are precursors of mammalian lignans in rats. J Nutr 2004; 134: 120–127
   PubMed Web of Science ®Google Scholar
• Mazur W, Adlercreutz H. Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Naturally occurring oestrogens in food. Pure Appl Chem 1998; 70: 1759–1776
   Web of Science ®Google Scholar
• Milder I EJ, Arts I CW, vandePutte B, Venema D P, Hollman P CH. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 2005; 93: 393–402
   PubMed Web of Science ®Google Scholar
• Penalvo J L, Haajanen K M, Botting N P, Adlercreutz H. Quantification of lignan in food using isotope dilution gas chromatography-mass spectrometry. J Agric Food Chem 2005; 53: 9342–9347
   PubMed Web of Science ®Google Scholar
• Thompson L U, Boucher B A, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006; 54: 184–201
   PubMed Web of Science ®Google Scholar
• Kurzer M S, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17: 353–381
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Human health and phytoestrogens. Reproductive and Developmental Toxicology, K S Korach. Marcel Dekker, New York 1998; 299–371
   Google Scholar
• Setchell K DR, Adlercreutz H. The excretion of two new phenolic compounds (180/442 and 180/410) during the human menstrual cycle and in pregnancy. J Steroid Biochem 1979; 11: xv–xvi
   Google Scholar
• Stitch S R, Toumba J K, Groen M B, Funke C W, Leemhuis J, Vink J, Woods G F. Excretion, isolation and structure of a phenolic constituent of female urine. Nature 1980; 287: 738–740
   PubMed Web of Science ®Google Scholar
• Setchell K DR, Lawson A M, Mitchell F L, Adlercreutz H, Kirk D N, Axelson M. Lignans in man and in animal species. Nature 1980; 287: 740–742
   PubMed Web of Science ®Google Scholar
• Setchell K DR, Bull R, Adlercreutz H. Steroid excretion during the reproductive cycle and in pregnancy of the vervet monkey (Ceropithecus aethiopus pygerethus). J Steroid Biochem Mol Biol 1980; 12: 375–384
   Google Scholar
• Setchell K DR, Lawson A M, Axelson M, Adlercreutz H. The excretion of two new phenolic compounds during the menstrual cycle and in pregnancy. Endocrinological Cancer, Ovarian Function and Disease, H Adlercreutz, R Bulbrook, H van der Molen, A Vermeulen, F Sciarra. International Congress Series No. 515, Excerpta Medica, Amsterdam 1980; 297–315
   Google Scholar
• Setchell K DR, Lawson A M, Borriello S P, Harkness R, Gordon H, Morgan D ML, Kirk D N, Adlercreutz H, Anderson L C, Axelson M. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 1981; 2: 4–7
   PubMed Web of Science ®Google Scholar
• Borriello S P, Setchell K DR, Axelson M, Lawson A M. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985; 58: 37–43
   PubMedGoogle Scholar
• Glitsø L V, Mazur W M, Adlercreutz H, Wähälä K, Mäkelä T, Sandströom B, Bach Knudsen K E. Intestinal metabolism of rye lignans in pigs. Br J Nutr 2000; 84: 429–437
   Web of Science ®Google Scholar
• Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Rafaelli B, Wähälä K, Deyama T, Nishibe S, Adlercreutz H. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 2001; 49: 3178–3186
   PubMed Web of Science ®Google Scholar
• Axelson M, Sjövall J, Gustafsson B E, Setchell K DR. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982; 298: 659–660
   PubMed Web of Science ®Google Scholar
• Xie L H, Ahn E M, Akao T, Abdel-Hafez A AM, Nakamura N, Hattori M. Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chem Pharm Bull (Tokyo) 2003; 51: 378–384
   PubMed Web of Science ®Google Scholar
• Nose M, Fujimoto T, Takeda T, Nishibe S, Ogihara Y. Structural transformation of lignan compounds in rat gastrointestinal tract. Planta Med 1992; 58: 520–523
   PubMedGoogle Scholar
• Saarinen N M, Wärri A, Mäkelä S I, Eckerman C, Reunanen M, Ahotupa M, Salmi S M, Franke A A, Kangas L, Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 2000; 36: 207–216
   PubMed Web of Science ®Google Scholar
• Clavel T, Henderson G, Engst W, Dore J, Blaut M. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol 2006; 55: 471–478
   PubMed Web of Science ®Google Scholar
• Wilkinson A P, Wähälä K, Williamson G. Identification and quantification of polyphenol phytoestrogens in foods and human biological fluids. J Chromatogr B 2002; 777: 93–109
   Google Scholar
• Hoikkala A A, Schiavoni E, Wähälä K. Analysis of phyto-oestrogens in biological matrices. Br J Nutr 2003; 89: S5–S18, (1 Suppl)
   Google Scholar
• Wu Q L, Wang M F, Simon J E. Analytical methods to determine phytoestrogenic compounds. J Chromatogr B 2004; 812: 325–355
   PubMed Web of Science ®Google Scholar
• Slanina J, Glatz Z. Separation procedures applicable to lignan analysis. J Chromatogr B 2004; 812: 215–229
   PubMed Web of Science ®Google Scholar
• Willför S M, Smeds A I, Holmbom B R. Chromatographic analysis of lignans. J Chromatogr 2006; 1112: 64–77
   PubMed Web of Science ®Google Scholar
• Penalvo J L, Nurmi T. Application of coulometric electrode array detection to the analysis of isoflavonoids and lignans. J Pharmac Biomed Anal 2006; 41: 1497–1507
   PubMed Web of Science ®Google Scholar
• Smeds A I, Hakala K, Hurmerinta T T, Kortela L, Saarinen N M, Makela S I. Determination of plant and enterolignans in human serum by high-performance liquid chromatography with tandem mass spectrometric detection. J Pharm Biomed Anal 2006; 41: 898–905
   Google Scholar
• Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Brunow G, Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin Chim Acta 1991; 199: 263–278
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Kiuru P, Rasku S, Wahala K, Fotsis T. An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine. J Steroid Biochem Mol Biol 2004; 92: 399–411
   PubMed Web of Science ®Google Scholar
• Grace P B, Taylor J I, Botting N P, Fryatt T, Oldfield M F, Bingham S A. Quantification of isoflavones and lignans in urine using gas chromatography/mass spectrometry. Anal Biochem 2003; 315: 114–121
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Wang G J, Lapcík O, Hampl R, Wähälä K, Mäkelä T, Lusa K, Talme M, Mikola H. Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 1998; 265: 208–215
   PubMed Web of Science ®Google Scholar
• Stumpf K, Uehara M, Nurmi T, Adlercreutz H. Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal Biochem 2000; 284: 153–157
   PubMedGoogle Scholar
• Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 1996; 233: 169–180
   PubMed Web of Science ®Google Scholar
• Kim K S, Park S H, Choung M G. Nondestructive determination of lignans and lignan glycosides in sesame seeds by near infrared reflectance spectroscopy. J Agric Food Chem 2006; 54: 4544–4550
   Google Scholar
• Mazur W. Phytoestrogen content in foods. Baillière's Clin Endocrinol Metab 1998; 12: 729–742
   PubMed Web of Science ®Google Scholar
• Nurmi T, Heinonen S, Mazur W, Deyama T, Nishibe S, Adlercreutz H. Lignans in selected wines. Food Chemistry 2003; 83: 303–309
   Google Scholar
• Mazur W M, Wähälä K, Rasku S, Salakka A, Hase T, Adlercreutz H. Lignan and isoflavonoid concentrations in tea and coffee. Br J Nutr 1998; 79: 37–45
   PubMed Web of Science ®Google Scholar
• Bonoli M, Bendini A, Cerretani L, Lercker G, Toschi T G. Qualitative and semiquantitative analysis of phenolic compounds in extra virgin olive oil as a function of the ripening degree of olive fruits by different analytical techniques. J Agric Food Chem 2004; 52: 7026–7032
   PubMed Web of Science ®Google Scholar
• Christophoridou S, Dais P, Tseng L H, Spraul M. Separation and identification of phenolic compounds in olive oil by coupling high-performance liquid chromatography with postcolumn solid-phase extraction to nuclear magnetic resonance spectroscopy (LC-SPE-NMR). J Agric Food Chem 2005; 53: 4667–4679
   PubMed Web of Science ®Google Scholar
• Mazur W M, Duke J A, Wähälä K, Rasku S, Adlercreutz H. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J Nutr Biochem 1998; 9: 193–200
   Web of Science ®Google Scholar
• Mazur W, Uehara M, Wähälä K, Adlercreutz H. Phytoestrogens in berries—plasma and urine enterolactone concentrations after a single strawberry meal. Br J Nutr 1998; 83: 381–387
   Google Scholar
• Liggins J, Grimwood R, Bingham S A. Extraction and quantification of lignan phytoestrogens in food and human samples. Anal Biochem 2000; 287: 102–109
   PubMed Web of Science ®Google Scholar
• Horn-Ross P L, Barnes S, Lee M, Coward L, Mandel J E, Koo J, John E M, Smith M. Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 2000; 11: 289–298
   PubMed Web of Science ®Google Scholar
• Valsta L M, Kilkkinen A, Mazur W, Nurmi T, Lampi A M, Ovaskainen M L, Korhonen T, Adlercreutz H, Pietinen P. Phyto-oestrogen database of foods and average intake in Finland. Br J Nutr 2003; 89: S31–S38, (1 Suppl)
   PubMed Web of Science ®Google Scholar
• Thompson L U, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991; 16: 43–52
   PubMed Web of Science ®Google Scholar
• Pillow P C, Duphorne C M, Chang S, Contois J H, Strom S S, Spitz M R, Hursting S D. Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer 1999; 33: 3–19
   PubMed Web of Science ®Google Scholar
• Kiely M, Faughnan M, Wähälä K, Brants H, Mulligan A. Phyto-oestrogen levels in foods: the design and construction of the VENUS database. Br J Nutr 2003; 89: S19–S23, (1 Suppl)
   PubMed Web of Science ®Google Scholar
• Blitz C L, Murphy S P, Donna L M. Adding lignan values to a food composition database. J Food Comp Analysis 2007; 20: 99–105
   Web of Science ®Google Scholar
• Milder I EJ, Arts L CW, Venema D P, Lasaroms J JP, Wähälä K, Hollman P CH. Optimization of a liquid chromatography-tandem mass spectrometry method for quantification of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in foods. J Agric Food Chem 2004; 52: 4643–4651
   PubMed Web of Science ®Google Scholar
• Kilkkinen A, Stumpf K, Pietinen P, Valsta L M, Tapanainen H, Adlercreutz H. Determinants of serum enterolactone concentration. Am J Clin Nutr 2001; 73: 1094–1100
   PubMed Web of Science ®Google Scholar
• Horner N K, Kristal A R, Prunty J, Skor H E, Potter J D, Lampe J W. Dietary determinants of plasma enterolactone. Cancer Epidem Biomarker Prev 2002; 11: 121–126
   PubMed Web of Science ®Google Scholar
• Milder I EJ, Feskens E JM, Arts I CW, deMesquita H BB, Hollman P CH, Kromhout D. Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J Nutr 2005; 135: 1202–1207
   PubMed Web of Science ®Google Scholar
• Hollman P C, Milder I E, Arts I C, Feskens E J, Bueno de Mesquita H B, Kromhout D. Phytoestrogens and risk of lung cancer. JAMA 2006; 295: 755
   Google Scholar
• Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986; 25: 791–797
   PubMedGoogle Scholar
• Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidem 2002; 155: 472–477
   PubMed Web of Science ®Google Scholar
• Linko A-M, Juntunen K S, Mykkänen H M, Adlercreutz H. Whole grain rye bread consumption correlates with plasma alkylresorcinols and increases their concentration compared to white wheat bread. J Nutr 2005; 135: 580–583
   PubMed Web of Science ®Google Scholar
• Johnsen N F, Hausner H, Olsen A, Tetens I, Christensen J, Knudsen K EB, Overvad K, Tjönneland A. Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. J Nutr 2004; 134: 2691–2697
   PubMed Web of Science ®Google Scholar
• Bach Kristensen M, Hels O, Tetens I. No changes in serum enterolactone levels after eight weeks intake of rye-bran products in healthy young men. Scand J Nutr 2005; 49: 62–67
   Google Scholar
• Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, Fotsis T, Ollus A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens, and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27: 1135–1144
   PubMedGoogle Scholar
• Lampe J W, Gustafson D R, Hutchins A M, Martini M C, Li S, Wähälä K, Grandits G A, Potter J D, Slavin J L. Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. Cancer Epidem Biomarker Prev 1999; 8: 699–707
   PubMed Web of Science ®Google Scholar
• Juntunen K S, Mazur W M, Liukkonen K H, Uehara M, Poutanen K S, Adlercreutz H CT, Mykkänen H M. Consumption of wholemeal rye bread increases serum concentrations and urinary excretion of enterolactone compared with consumption of white wheat bread in healthy Finnish men and women. Br J Nutr 2000; 84: 839–846
   PubMed Web of Science ®Google Scholar
• Kilkkinen A, Valsta L M, Virtamo J, Stumpf K, Adlercreutz H, Pietinen P. Intake of lignans is associated with serum enterolactone concentration in Finnish men and women. J Nutr 2003; 133: 1830–1833
   PubMed Web of Science ®Google Scholar
• McIntosh G H, Noakes M, Royle P J, Foster P R. Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men. Am J Clin Nutr 2003; 77: 967–974
   PubMed Web of Science ®Google Scholar
• Jacobs D R, Pereira M A, Stumpf K, Pins J J, Adlercreutz H. Whole grain food intake elevates serum enterolactone. Br J Nutr 2002; 88: 111–116
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Fotsis T, Heikkinen R, Dwyer J T, Goldin B R, Gorbach S L, Lawson A M, Setchell K DR. Diet and urinary excretion of lignans in female subjects. Med Biol 1981; 59: 259–261
   PubMedGoogle Scholar
• Jordan V C, Koch R, Bain R R. Prolactin synthesis by cultured rat pituitary cells: an assay to study estrogens, antiestrogens and their metabolites in vitro. Estrogens in the Environment II Influences on Development, J A McLachlan. Elsevier, New York 1985; 221–234
   Google Scholar
• Pettersson K, Gustafsson J A. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001; 63: 165–192
   PubMed Web of Science ®Google Scholar
• Mueller S O, Simon S, Chae K, Metzler M, Korach K S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ER alpha) and ER beta in human cells. Toxicol Sci 2004; 80: 14–25
   PubMed Web of Science ®Google Scholar
• Welshons W V, Murphy C S, Koch R, Calaf G, Jordan V C. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 1987; 10: 169–175
   PubMed Web of Science ®Google Scholar
• Waters A P, Knowler J T. Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J Reprod Fertil 1982; 66: 379–381
   PubMedGoogle Scholar
• Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 1992; 41: 615–619
   PubMed Web of Science ®Google Scholar
• Power K A, Saarinen N M, Chen J M, Thompson L U. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 2006; 118: 1316–1320
   PubMed Web of Science ®Google Scholar
• Bergman-Jungestrom M, Thompson L U, Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 2007; 13: 1061–1067
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Davis V L, Tally W C, Korkman J, Salo L, Vihko R, Santti R, Korach K S. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 1994; 102: 572–578
   PubMed Web of Science ®Google Scholar
• Sathyamoorthy N, Wang T TY, Phang J M. Stimulation of pS2 expression by diet-derived compounds. Cancer Res 1994; 54: 957–961
   PubMed Web of Science ®Google Scholar
• Whitten P L, Naftolin F. Dietary estrogens—a biologically active background for estrogen action. New Biology of Steroid Hormones, R B Hochberg, F Naftolin. Raven Press, New York 1991; 155–167
   Google Scholar
• Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Hämäläinen E, Wähälä K, Mäkelä T, Hase T. Dietary phytoestrogens and cancer: in vitro, in vivo studies. J Steroid Biochem Mol Biol 1992; 41: 331–337
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Fotsis T, Lampe J, Wähälä K, Mäkelä T, Brunow G, Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas-chromatography mass-spectrometry. Scand J Clin Lab Invest 1993; 53: 5–18
   Web of Science ®Google Scholar
• Clark J H, Hardin J W, Upchurch S. Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. J Biol Chem 1978; 253: 7630–7634
   PubMed Web of Science ®Google Scholar
• Markaverich B M, Clark J H. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response. Endocrinology 1979; 105: 1458–1462
   PubMed Web of Science ®Google Scholar
• Markaverich B M, Upchurch S, Clark J H. Progesterone and dexamethasone antagonism of uterine growth: a role for a second nuclear binding site for estradiol in estrogen action. J Steroid Biochem 1981; 14: 125–132
   PubMedGoogle Scholar
• Markaverich B M, Roberts R R, Alejandro M A, Clark J H. An endogenous inhibitor of (3H)estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res 1984; 44: 1515–1519
   Google Scholar
• Markaverich B M, Gregory R R, Alejandro M-A, Clark J H, Johnson G A, Middleditch B S. Methyl p-hydroxyphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type II binding sites. J Biol Chem 1988; 263: 7203–7210
   PubMedGoogle Scholar
• Markaverich B M, Roberts R R, Alejandro M, Johnson G A, Middleditch B S, Clark J H. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J Steroid Biochem 1988; 30: 71–78
   PubMedGoogle Scholar
• Markaverich B M, Schauweker T H, Gregory R R, Varma M, Kittrell F S, Medina D, Varma R S. Nuclear type-II sites and malignant cell proliferation—inhibition by 2,6-bis-benzylidenecyclohexanones. Cancer Res 1992; 52: 2482–2488
   PubMed Web of Science ®Google Scholar
• Markaverich B M, Webb B, Densmore C L, Gregory R R. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect 1995; 103: 574–581
   PubMed Web of Science ®Google Scholar
• Garai J, Tiller A A, Clark J H. Tyrosinase-like polypeptides in the uterus and in the central nervous system of rats. Steroids 1992; 57: 183–188
   PubMed Web of Science ®Google Scholar
• Garai J, Clark J H. Tyrosinase-like activity and estradiol binding in rat uterine nuclear extracts. Steroids 1992; 57: 248–256
   Google Scholar
• Garai J, Clark J H. Estrogen affinity crosslinking to tyrosinase-like immunoreactive proteins of rat uterine nuclear extracts. J Steroid Biochem Mol Biol 1994; 49: 161–165
   Google Scholar
• Densmore C L, Schauweker T H, Gregory R R, Webb B, Garcia E, Markaverich B M. Chromatographic resolution of the type II estrogen binding site and a tyrosinase-like enzymatic activity from rat uterine nuclei. Steroids 1994; 59: 282–287
   Google Scholar
• Shoulars K, Brown T, Alejandro M A, Crowley J, Markaverich B M. Identification of nuclear type II (3H)estradiol binding sites as histone H4. Biochem Biophys Res Commun 2002; 296: 1083–1090
   Google Scholar
• Shoulars K, Rodrigues M A, Crowley J R, Turk J, Thompson T, Markaverich B M. Nuclear type II (3H)estradiol binding sites: a histone H3-H4 complex. J Steroid Biochem Molec Biol 2005; 96: 19–30
   Google Scholar
• Shoulars K, Rodriguez M A, Crowley J, Turk J, Thompson T, Markaverich B M. Reconstitution of the type II (3H)estradiol binding site with recombinant histone H4. J Steroid Biochem Mol Biol 2006; 99: 1–8
   Google Scholar
• Attalla H, Mäkelä T P, Wähälä K, Rasku S, Andersson L C, Adlercreutz H. 2,6-bis((3,4-dihydroxyphenyl)-methylene)cyclohexanone (BDHPC)-induced apoptosis and p53-independent growth inhibition: synergism with genistein. Biochem Biophys Res Commun 1997; 239: 467–472
   Google Scholar
• Markaverich B M, Schoulars K, Alejandro M A. Nuclear type II (3H)estradiol binding site ligands: inhibition of ER-positive and ER-negative cell proliferation and c-Myc and cyclin D1 gene expression. Steroids 2006; 71: 865–874
   Google Scholar
• Markaverich B M, Shoulars K, Brown M AT. Purification and characterization of nuclear type II(H-3)estradiol binding sites from the rat uterus: covalent labeling with (H-3)luteolin. Steroids 2001; 66: 707–719
   Google Scholar
• Garai J, Adlercreutz H. Estrogen-inducible uterine flavonoid binding sites: is it time to reconsider. J Steroid Biochem Mol Biol 2004; 88: 377–381
   Google Scholar
• Molnar V, Garasi J. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity. Int Immunopharmacol 2005; 5: 849–856
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Hämäläinen E, Gorbach S L, Goldin B R, Woods M N, Dwyer J T. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989; 49: 433–442
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Höckerstedt K, Bannwart C, Hämäläinen E, Fotsis T, Bloigu S. Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. Progress in Cancer Research and Therapy, Vol 35: Hormones and Cancer 3, F Bresciani, R JB King, M E Lippman, J-P Raynaud. Raven Press, New York 1988; 409–412
   Google Scholar
• Zeleniuch-Jacquotte A, Adlercreutz H, Shore R E, Koenig K L, Kato I, Arslan A A, Toniolo P. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 2004; 91: 99–105
   PubMed Web of Science ®Google Scholar
• Monroe K R, Murphy S P, Henderson B E, Kolonel L N, Stanczyk F Z, Adlercreutz H, Pike M C. Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican-American women: the multiethnic cohort study. Nutr Cancer 2007; 58: 127–135
   PubMed Web of Science ®Google Scholar
• Schöttner M, Spiteller G, Gansser D. Lignans interfering with 5α -dihydrotestosterone binding to human sex hormone-binding globulin. J Nat Prod 1998; 61: 119–121
   Google Scholar
• Rosner W, Hryb D J, Khan M S, Nakhla A M, Romas N A. Sex hormone-binding globulin—anatomy and physiology of a new regulatory system. J Steroid Biochem Mol Biol 1991; 40: 813–820
   PubMed Web of Science ®Google Scholar
• Hammond G L. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab 1995; 6: 298–304
   PubMed Web of Science ®Google Scholar
• Shultz T D, Bonorden W R, Seaman W R. Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men. Nutr Res 1991; 11: 1089–1100
   Google Scholar
• Phipps W R, Martini M C, Lampe J W, Slavin J L, Kurzer M S. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993; 77: 1215–1219
   PubMed Web of Science ®Google Scholar
• Hutchins A M, Martini M C, Olson B A, Thomas W, Slavin J L. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001; 39: 58–65
   PubMed Web of Science ®Google Scholar
• Pino A M, Valladares L E, Palma M A, Mancilla A M, Yanez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000; 85: 2797–2800
   PubMed Web of Science ®Google Scholar
• Wu W H, Kang Y P, Wang N H, Jou H J, Wang T A. Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr 2006; 136: 1270–1275
   PubMed Web of Science ®Google Scholar
• Liu Z, Saarinen N M, Thompson L U. Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats. J Nutr 2006; 136: 906–912
   PubMed Web of Science ®Google Scholar
• Coulman K D, Liu Z, Hum W Q, Michaelides J, Thompson L U. Whole sesame seed is as rich a source of mammalian lignan precursors as whole flaxseed. Nutr Cancer 2005; 52: 156–165
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002; 3: 364–373
   PubMed Web of Science ®Google Scholar
• Boccardo F, Lunardi G L, Petti A R, Rubagotti A. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. Breast Cancer Res Treat 2003; 79: 17–23
   PubMed Web of Science ®Google Scholar
• Rickard S E, Yuan Y V, Thompson L U. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 2000; 161: 47–55
   PubMedGoogle Scholar
• Vrieling A, Voskuil D W, Bueno de Mesquita H B, Kaaks R, van Noord P A, Keinan-Boker L, van Gils C H, Peeters P H. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Cancer Causes Control 2004; 15: 787–796
   PubMed Web of Science ®Google Scholar
• Woodside J V, Campbell M J, Denholm E E, Newton L, Honour J W, Morton M S, Young I S, Leathem A JC. Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J Nutr Biochem 2006; 17: 211–215
   PubMed Web of Science ®Google Scholar
• Mawson A, Lai A, Carroll J S, Sergio C M, Mitchell C J, Sarcevic B U. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 2005; 229: 161–173
   PubMed Web of Science ®Google Scholar
• Kitts W D, Newsome F E, Runeckles V C. The estrogenic and antiestrogenic effects of coumestrol and zearalanol on the immature rat uterus. Can J Anim Sci 1983; 63: 823–834
   Google Scholar
• Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 2000; 9: 220–225
   PubMedGoogle Scholar
• Giovannucci E. Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Hormone Res 1999; 51: 34–41
   PubMed Web of Science ®Google Scholar
• Evans B AJ, Griffiths K, Morton M S. Inhibition of 5α -reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295–302
   PubMed Web of Science ®Google Scholar
• Low Y L, Taylor J I, Grace P B, Dowsett M, Folkerd E, Doody D, Dunning A M, Scollen S, Mulligan A A, Welch A A, Luben R N, Khaw K T, Day N E, Wareham N J, Bingham S A. Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men. J Nutr 2005; 135: 2680–2686
   PubMed Web of Science ®Google Scholar
• Miller W R. Aromatase activity in breast tissue. J Steroid Biochem Mol Biol 1991; 39: 783–790
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena P J, Kellis J T, Jr., Vickery L E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147–153
   PubMed Web of Science ®Google Scholar
• Brooks J D, Thompson L U. Mammalian lignans and genistein decrease the activities of aromatase and 17 beta-hydroxy steroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 2005; 94: 461–467
   PubMed Web of Science ®Google Scholar
• Mäkelä S, Poutanen M, Lehtimäki J, Kostian M L, Santti R, Vihko R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (EC 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 1995; 208: 51–59
   PubMed Web of Science ®Google Scholar
• Gansser D, Spiteller G. Aromatase inhibitors from urtica dioica roots. Planta Med 1995; 61: 138–140
   PubMed Web of Science ®Google Scholar
• Campbell D R, Kurzer M S. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 1993; 46: 381–388
   PubMed Web of Science ®Google Scholar
• Wang C F, Mäkelä T, Hase T, Adlercreutz H, Kurzer M S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994; 50: 205–212
   PubMed Web of Science ®Google Scholar
• Henderson B E, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal foundation award lecture. Cancer Res 1988; 48: 246–253
   PubMed Web of Science ®Google Scholar
• Jacobs M N, Nolan G T, Hood S R. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol 2005; 209: 123–133
   PubMed Web of Science ®Google Scholar
• Bylund A, Lundin E, Zhang J X, Nordin A, Kaaks R, Stenman U-H, Åman P, Adlercreutz H, Nilsson T K, Hallmans G, Bergh A, Stattin P. Randomized controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev 2003; 12: 407–415
   PubMed Web of Science ®Google Scholar
• Thompson L U, Chen J M, Li T, Strasser-Weippl K, Goss P E. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005; 11: 3828–3835
   PubMed Web of Science ®Google Scholar
• Yan L, Yee J A, Li D H, Mcguire M H, Thompson L U. Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett 1998; 124: 181–186
   PubMed Web of Science ®Google Scholar
• Rickard S E, Yuan Y V, Chen J M, Thompson L U. Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 1999; 35: 50–57
   PubMed Web of Science ®Google Scholar
• Li D H, Yee J A, Thompson L U, Yan L. Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett 1999; 142: 91–96
   PubMed Web of Science ®Google Scholar
• Chen J M, Stavro P M, Thompson L U. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 2002; 43: 187–192
   PubMed Web of Science ®Google Scholar
• Dabrosin C, Chen J M, Wang L, Thompson L U. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 2002; 185: 31–37
   PubMed Web of Science ®Google Scholar
• Saarinen N M, Huovinen R, Warri A, Mäkelä S I, Valentin-Blasini L, Sjöholm R, Ämmälä J, Lehtilä R, Eckerman C, Collan Y U, Santti R S. Enterolactone inhibits the growth of 7,12-dimethylbenz(A) anthracene-induced mammary carcinomas in the rat. Mol Cancer Ther 2002; 1: 869–876
   PubMed Web of Science ®Google Scholar
• Chen J, Thompson L U. Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 2003; 80: 163–170
   PubMed Web of Science ®Google Scholar
• Wang L, Chen J M, Thompson L U. The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 2005; 116: 793–798
   PubMed Web of Science ®Google Scholar
• Bylund A, Saarinen N, Zhang J X, Bergh A, Widmark A, Johansson A, Lundin E, Adlercreutz H, Hallmans G, Stattin P, Makela S. Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med 2005; 230: 217–223
   PubMed Web of Science ®Google Scholar
• Saarinen N M, Power K, Chen J, Thompson L U. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer 2006; 119: 925–931
   PubMed Web of Science ®Google Scholar
• Smeds A I, Saarinen N M, Hurmerinta T T, Penttinen P E, Sjöholm R E, Mäkelä S I. Urinary excretion of lignans after administration of isolated plant lignans to rats: the effect of single dose and ten-day exposures. J Chromatogr B 2004; 813: 303–312
   PubMed Web of Science ®Google Scholar
• Saarinen N M, Penttinen P E, Smeds A I, Hurmerinta T T, Mäkelä S I. Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo. J Steroid Biochem Mol Biol 2005; 93: 209–219
   Google Scholar
• Magee P J, Rowland I R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004; 91: 513–531
   PubMed Web of Science ®Google Scholar
• Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004; 65: 995–1016
   PubMed Web of Science ®Google Scholar
• Webb A L, McCullough M L. Dietary lignans: Potential role in cancer prevention. Nutr Cancer 2005; 51: 117–131
   PubMed Web of Science ®Google Scholar
• Boccardo F, Puntoni M, Guglielmini P, Rubagotti A U. Enterolactone as a risk factor for breast cancer: a review of the published evidence. Clin Chim Acta 2006; 365: 58–67
   Google Scholar
• Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990–994
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Lignans and phytoestrogens. Possible preventive role in cancer. Progress in Diet and Nutrition, Frontiers of Gastrointestinal Research 14, C Horwitz, P Rozen. S. Karger, Basel 1988; 165–176
   Google Scholar
• Burkitt D P. Colonic-rectal cancer: fiber and other dietary factors. Am J Clin Nutr 1978; 31: S58–S64, (10 Suppl)
   Google Scholar
• Goldin B R, Adlercreutz H, Gorbach S L, Warram J H, Dwyer J T, Swenson L, Woods M N. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 1982; 307: 1542–1547
   PubMed Web of Science ®Google Scholar
• Adlercreutz H. Diet and sex hormone metabolism. Nutrition, Toxicity, and Cancer, I R Rowland. CRC Press, Boca Raton 1991; 137–195
   Google Scholar
• Adlercreutz H, Gorbach S L, Goldin B R, Woods M N, Dwyer J T, Hämäläinen E. Estrogen metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst 1994; 86: 1076–1082
   PubMed Web of Science ®Google Scholar
• Rock C L, Flatt S W, Thomson C A, Stefanick M L, Newman V A, Jones L A, Natarajan L, Ritenbaugh C, Hollenbach K A, Pierce J P, Chang R J. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 2004; 22: 2379–2387
   PubMed Web of Science ®Google Scholar
• Willett W C, Hunter D J, Stampfer M J, Colditz G, Manson J E, Spiegelman D, Rosner B, Hennekens C H, Speizer F E. Dietary fat and fiber in relation to risk of breast cancer. JAMA 1992; 21: 2037–2044
   Google Scholar
• Willett W C. Dietary fat and risk of breast and colon cancer. Proc Nutr Soc 1994; 53: 25–26
   PubMedGoogle Scholar
• Consensus meeting on cereals, fiber and colorectal and breast cancers. ECP consensus panel on cereals and cancer (published erratum appears in Eur J Cancer Prev 1998 Feb;7(1):83). Eur J Cancer Prev 1997; 6: 512–514
   Google Scholar
• Prentice R L, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 629–642
   PubMed Web of Science ®Google Scholar
• Beresford S A, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 643–654
   PubMed Web of Science ®Google Scholar
• Korpela J T, Adlercreutz H, Turunen M J. Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and in patients with colorectal cancer. Scand J Gastroenterol 1988; 23: 277–283
   PubMed Web of Science ®Google Scholar
• Korpela J T, Korpela R, Adlercreutz H. Fecal bile acid metabolic pattern after administration of different types of bread. Gastroenterology 1992; 103: 1246–1253
   PubMed Web of Science ®Google Scholar
• Hallmans G, Zhang J-X, Lundin E, Bergh A, Landström M, Sylvan A, Bylund A, Widmark A, Damber J-E, Åman P, Johansson A, Adlercreutz H. Metabolism of lignans and their relation to experimental prostate cancer, S Bausch-Goldbohm, A Kardinaal, F Serra. European Communities, DoorwethThe Netherlands 1998; 65–72
   Google Scholar
• Bach Knudsen K E, Serena A, Adlercreutz H. Cereal fiber sources that enhance the production and plasma concentrations of enterolignans and butyrate. Agric Food Industry High-Tech 2007, in press
   Google Scholar
• Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz B. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res 2000; 12: 83–95
   PubMed Web of Science ®Google Scholar
• Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliövaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?. Br J Cancer 2000; 82: 1107–1110
   Google Scholar
• Velicer C M, Heckbert S R, Lampe J W, Potter J D, Robertson C A, Taplin S H. Antibiotic use in relation to the risk of breast cancer. JAMA 2004; 291: 827–835
   PubMed Web of Science ®Google Scholar
• Rodriguez L AG, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005; 161: 616–619
   Google Scholar
• Sørensen H T, Skriver M V, Friis S, McLaughlin J, Blot W J, Baron J A. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005; 92: 594–596
   PubMedGoogle Scholar
• Dehennin L, Reiffsteck A, Joudet M, Thibier M. Identification and quantitative estimation of a lignan in human and bovine semen. J Reprod Fertil 1982; 66: 305–309
   PubMedGoogle Scholar
• Hong S J, Kim S I, Kwon S M, Lee J R, Chung B C. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 2002; 43: 236–241
   PubMed Web of Science ®Google Scholar
• Rannikko A, Petas A, Rannikko S, Adlercreutz H. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestrogen supplementation. Prostate 2006; 66: 82–87
   PubMed Web of Science ®Google Scholar
• Brössner C, Petritsh K, Fink K, Auprich M, Ponholzer A, Madersbacher S, Adlercreutz H, Petritsch P. Prostatic phyto-oestrogen tissue levels in different Austrian regions. Urologia 2006; 76: 327–331
   Google Scholar
• Rossini A, Rumio C, Sfondrini L, Tagliabue E, Morelli D, Miceli R, Mariani L, Palazzo M, Menard S, Balsari A. Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res 2006; 66: 6219–6224
   Google Scholar
• Tou J CL, Thompson L U. Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 1999; 20: 1831–1835
   PubMed Web of Science ®Google Scholar
• Ward W E, Jiang F O, Thompson L U. Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr Cancer 2000; 37: 187–192
   PubMed Web of Science ®Google Scholar
• Thompson L U. Flaxseed, lignans, and cancer. Flaxseed in Human Nutrition, S C Cunnane, L U Thompson. AOCS Press, Champaign, Illinois 1995; 219–236
   Google Scholar
• Thompson L U. Experimental studies on lignans and cancer. Bailliere's Clin Endocrinol Metab 1998; 12: 691–705
   PubMed Web of Science ®Google Scholar
• Chen J, Wang L, Thompson L U. Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 2006; 234: 168–175
   PubMed Web of Science ®Google Scholar
• Olsen A, Knudsen K E, Thomsen B L, Loft S, Stripp C, Overvad K, Möller S, Tjönneland A. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidem Biomark Prev 2004; 13: 2084–2089
   PubMed Web of Science ®Google Scholar
• McCann S E, Kulkarni S, Trevisan M, Vito D, Nie J, Edge S B, Muti P, Freudenheim J L. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 2006; 99: 309–311
   PubMed Web of Science ®Google Scholar
• Chen J M, Tan K P, Ward W E, Thompson L U. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med 2003; 228: 951–958
   PubMed Web of Science ®Google Scholar
• Tan K P, Chen J M, Ward W E, Thompson L U. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med 2004; 229: 147–157
   PubMed Web of Science ®Google Scholar
• Thanos J, Cotterchio M, Boucher B A, Kreiger N, Thompson L U. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006; 17: 1253–1261
   PubMed Web of Science ®Google Scholar
• Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, Nishibe S, Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 2000; 155: 79–88
   PubMed Web of Science ®Google Scholar
• Stumpf K, Adlercreutz H. Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrations. Clin Chem 2003; 49: 178–181
   PubMed Web of Science ®Google Scholar
• Vanharanta M, Voutilainen S, Lakka T A, van der Lee M, Adlercreutz H, Salonen J T. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 1999; 354: 2112–2115
   PubMed Web of Science ®Google Scholar
• Pietinen P, Stumpf K, Männistö S, Kataja V, Adlercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidem Biomark Prev 2001; 70: 339–344
   Google Scholar
• Vanharanta M, Voutilainen S, Rissanen T H, Adlercreutz H, Salonen J T. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone—Kuopio ischaemic heart disease risk factor study. Arch Intern Med 2003; 163: 1099–1104
   PubMedGoogle Scholar
• Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on the lignan enterolactone and breast cancer. Eur J Nutr 2002; 41: 168–176
   PubMedGoogle Scholar
• Keinan-Boker L, van Der Schouw Y T, Grobbee D E, Peeters P H. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004; 79: 282–288
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Keinan-Boker L, Van't Veer P, Arts C JM, Adlercreutz H, Thijssen J HH, Peeters P HM. Urinary phyto-oestrogens and breast cancer risk. Cancer Epidem Biomark Prev 2001; 10: 223–228
   PubMed Web of Science ®Google Scholar
• Horn-Ross P L, John E M, Lee M, Stewart S L, Koo J, Sakoda L C, Shiau A G, Goldstein J, Davis P, Perez-Stable E J. Phytoestrogen consumption and breast cancer risk in a multiethnic population—The Bay Area Breast Cancer Study. Am J Epidemiol 2001; 154: 434–441
   PubMed Web of Science ®Google Scholar
• Horn-Ross P L, Hoggatt K J, West D W, Krone M R, Stewart S L, Anton H, Bernstei C L, Deapen D, Peel D, Pinder R, Reynolds P, Ross R K, Wright W, Ziogas A. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002; 13: 407–415
   PubMed Web of Science ®Google Scholar
• Stumpf K. Serum enterolactone as a biological marker and in breast cancer: From laboratory to epidemiological studies. University of Helsinki, Helsinki 2004
   Google Scholar
• Stumpf K, Pietinen P, Puska P, Wang G, Adlercreutz H. Determination of serum enterolactone, genistein and daidzein in samples from the North Karelian intervention study. Cancer Epidem Biomark Prev 2001; 9: 1369–1372
   Google Scholar
• Kilkkinen A, Virtamo J, Vartiamen E, Sankila R, Virtanen M J, Adlercreutz H, Pietinen P. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 2004; 108: 277–280
   PubMed Web of Science ®Google Scholar
• Smith-Warner S A, Spiegelman D, Yaun S S, Adami H O, Beeson W L, van den Brandt P A, Folsom A R, Fraser G E, Freudenheim J L, Goldbohm R A, Graham S, Miller A B, Potter J D, Rohan T E, Speizer F E, Toniolo P, Willett W C, Wolk A, Zeleniuch-Jacquotte A, Hunter D J. Intake of fruits and vegetables and risk of breast cancer - A pooled analysis of cohort studies. JAMA 2001; 285: 769–776
   PubMed Web of Science ®Google Scholar
• Hung H C, Joshipura K J, Jiang R, Hu F B, Hunter D, Smith Warner S A, Colditz G A, Rosner B, Spiegelman D, Willett W C. Fruit and vegetable intake and risk of major chronic disease. J Nat Cancer Inst 2004; 96: 1577–1584
   PubMed Web of Science ®Google Scholar
• van Gils C H, et al. Consumption of vegetables and fruits and risk of breast cancer. JAMA 2005; 293: 183–193
   PubMed Web of Science ®Google Scholar
• Olsen A, Stripp C, Christense J, Thomsen B L, Overvad K, Tjonneland A. Re: Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 2005; 97: 1307–1308
   Google Scholar
• Touillaud M S, Thiebaut A C, Niravong M, Boutron-Ruault M C, Clavel-Chapelon F. No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidem Biomark Prev 2006; 15: 2574–2576
   PubMed Web of Science ®Google Scholar
• McCann S E, Moysich K B, Freudenheim J L, Ambrosone C B, Shields P G. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 2002; 132: 3036–3041
   PubMed Web of Science ®Google Scholar
• Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans. J Nutr 2006; 136: 1596–1603
   PubMed Web of Science ®Google Scholar
• Linseisen J, Piller R, Hermann S, Chang Claude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2004; 110: 284–290
   PubMed Web of Science ®Google Scholar
• Piller R A, Chang-Claude J B, Linseisen J AB. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 2006; 15: 225–232
   PubMed Web of Science ®Google Scholar
• McCann S E, Muti P, Vito D, Edge S B, Trevisan M, Freudenheim J L. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 2004; 111: 440–443
   PubMed Web of Science ®Google Scholar
• Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 2004; 40: 84–89
   Google Scholar
• Touillaud M S, Pillow P C, Jakovljevic J, Bondy M L, Singletary S E, Li D H, Chang S N. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 2005; 51: 162–169
   PubMed Web of Science ®Google Scholar
• Touillaud M S, Thiébaut A CM, Fournier A, Niravong M, Boutron-Ruault M-C, Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 2007; 99: 475–486
   PubMed Web of Science ®Google Scholar
• Ha T C, Lyons-Wall P M, Moore D E, Tattam B N, Boyages J, Ung O A, Taylor R J. Phytoestrogens and indicators of breast cancer prognosis. Nutr Cancer 2006; 56: 3–10
   PubMed Web of Science ®Google Scholar
• Grace P B, Taylor J I, Low Y L, Luben R N, Mulligan A A, Botting N P, Dowsett M, Welch A A, Khaw K T, Wareham N J, Day N E, Bingham S A. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidem Biomark Prev 2004; 13: 698–708
   PubMed Web of Science ®Google Scholar
• Verheus M, Peeters P H, Kaaks R, van Noord P A, Grobbee D E, van Gils C H. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomark Prev 2007; 16: 451–457
   Google Scholar
• McCann M J, Gill C IR, McGlynn H, Rowland I R. Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr Cancer 2005; 52: 1–14
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm N V, Verkasalo P K, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78–85
   PubMed Web of Science ®Google Scholar
• Wu K, Hu F B, Willett W C, Giovannucci E. Dietary patterns and risk of prostate cancer in U.S. men. Cancer Epidem Biomark Prev 2006; 15: 167–171
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Caamano Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidem Biomark Prev 2004; 13: 340–345
   PubMed Web of Science ®Google Scholar
• Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L, Montella M, Conti E, La Vecchia C. Fiber intake and prostate cancer risk. Int J Cancer 2004; 109: 278–280
   PubMedGoogle Scholar
• Key T J, et al. Fruits and vegetables and prostate cancer: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004; 109: 119–124
   PubMed Web of Science ®Google Scholar
• Hebert J R, Hurley T G, Olendzki B C, Teas J, Ma Y, Hampl J S. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998; 90: 1637–1647
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Bartels P, Elomaa V-V, Kang C. Phytoestrogens and prostate cancer. Soy & Health 2000 Clinical evidence—Dietetic applications, K Descheemaker, I Debruyne. Garant, Leuven/Apeldoorn 2000; 61–71
   Google Scholar
• McCann M J, Gill C I, McGlynn H, Rowland I R. Effect of selected lignans on the cell cycle of PC-3 human prostate cancer cell lines. Polyphenols Commun 2004; P43: 289–290
   Google Scholar
• Lin X, Switzer B R, Demark-Wahnefried W. Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res 2001; 21: 3995–3999
   PubMedGoogle Scholar
• Lin X, Gingrich J R, Bao W, Li J, Haroon Z A, Demark-Wahnefried W. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 2002; 60: 919–924
   PubMed Web of Science ®Google Scholar
• Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 2000; 87: 434–437
   PubMed Web of Science ®Google Scholar
• Landström M, Zhang J X, Hallmans G, Aman P, Bergh A, Damber J-E, Mazur W, Wähälä K, Adlercreutz H. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 1998; 36: 151–161
   PubMed Web of Science ®Google Scholar
• Bylund A, Zhang J X, Bergh A, Damber J E, Widmark A, Johansson A, Adlercreutz H, Åman P, Shepherd M J, Hallmans G. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 2000; 42: 304–314
   PubMed Web of Science ®Google Scholar
• Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control. Int J Cancer 2002; 99: 124–129
   PubMed Web of Science ®Google Scholar
• Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 2004; 15: 1095–1102
   PubMed Web of Science ®Google Scholar
• Kilkkinen A, Virtamo J, Virtanen M J, Adlercreutz H, Albanes D, Pietinen P. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidem Biomark Prev 2003; 12: 1209–1212
   PubMed Web of Science ®Google Scholar
• McCann S E, Ambrosone C B, Moysich K B, Brasure J, Marshall J R, Freudenheim J L, Wilkinson G S, Graham S. Intakes of selected nutrients, food, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 2005; 53: 33–41
   PubMed Web of Science ®Google Scholar
• Hedelin M, Klint Å, Chang E T, Belloco R, Andersson S O, Heinonen S M, Adlercreutz H, Adami H O, Grönberg H, Johansson J E, Bälter K A. Dietary phytoestrogens, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study (Sweden). Cancer Causes Control 2006; 17: 169–180
   PubMed Web of Science ®Google Scholar
• Mantzoros C S, Tzonou A, Signorello L B, Stampfer M, Trichopoulos D, Adaml H O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997; 76: 1115–1118
   PubMed Web of Science ®Google Scholar
• Pollak M, Beamer W, Zhang J C. Insulin-like growth factors and prostate cancer. Cancer Metast Rev 1998; 17: 383–390
   PubMed Web of Science ®Google Scholar
• Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman U H, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000; 92: 1910–1917
   PubMed Web of Science ®Google Scholar
• Stattin P, Rinaldi S, Biessy C, Stenman U H, Hallmans G, Kaaks R. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort. J Clin Oncol 2004; 22: 3104–3112
   PubMed Web of Science ®Google Scholar
• Finne P, Auvinen A, Koistinen H, Zhang W M, Maattanen L, Rannikko S, Tammela T, Seppala M, Hakama M, Stenman U H. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab 2000; 85: 2744–2747
   PubMed Web of Science ®Google Scholar
• Woodson K, Tangrea J A, Pollak M, Copeland T D, Taylor P R, Virtamo J, Albanes D. Serum insulin-like growth factor 1: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 2003; 63: 3991–3994
   PubMed Web of Science ®Google Scholar
• Tsubaki J, Choi W-K, Ingermann A R, Twigg S M, Kim H-S, Rosenfeld R G, Oh Y. Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells. J Endocrinol 2001; 169: 97–110
   Google Scholar
• Tsubaki J, Hwa V, Twigg S M, Rosenfeld R G. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells. Endocrinology 2002; 143: 1778–1788
   Google Scholar
• Sung M K, Lautens M, Thompson L U. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998; 18: 1405–1408
   PubMedGoogle Scholar
• Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, Tsubura A. Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res 2005; 25: 2269–2276
   PubMed Web of Science ®Google Scholar
• Wang W Q, Liu L Q, Higuchi C M, Chen H W. Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 1998; 56: 189–195
   PubMed Web of Science ®Google Scholar
• Mutanen M, Pajari A-M, Oikarinen S I. Beef induces and rye bran prevents the formation of intestinal polyps in ApcMin mice: relation to β-catenin and PKC isozymes. Carcinogenesis 2000; 21: 1167–1173
   PubMedGoogle Scholar
• Oikarinen S I, Pajari A-M, Mutanen M. Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in ApcMin mice. Cancer Lett 2000; 161: 253–258
   PubMedGoogle Scholar
• Sheng H, Hirose Y, Hata K Q. Z, T. K, Asano N, Yamada Y, Hara A T. O, Mori H. Modifying effect of dietary sesaminol glucosides on the formation of azoxymethane-induced premalignant lesions of rat colon. Cancer Lett 2007; 246: 63–68
   Google Scholar
• van Kranen H J, Mortensen A, Sorensen I K, van den Berg-Wijnands J, Beems R, Nurmi T, Adlercreutz H, van Kreijl C F. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in Apc(Min) mice. Nutr Cancer 2003; 45: 203–210
   PubMed Web of Science ®Google Scholar
• Oikarinen S, Heinonen S M, Nurmi T, Adlercreutz H, Mutanen M. No effect on adenoma formation in Min mice after moderate amount of flaxseed. Eur J Nutr 2005; 44: 273–280
   Google Scholar
• Pajari A-M, Smeds A I, Oikarinen S I, Eklund P C, Sjöholm R E, Mutanen M. The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation. Cancer Lett 2006; 233: 309–314
   PubMed Web of Science ®Google Scholar
• Kuijsten A, Arts I CW, Hollman P CH, van't Veer P, Kampman E. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidem Biomark Prev 2006; 15: 1132–1136
   PubMed Web of Science ®Google Scholar
• Cotterchio M, Boucher B A, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colon cancer risk. J Nutr 2006; 136: 3046–3053
   PubMed Web of Science ®Google Scholar
• Park Y, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005; 294: 2849–2857
   PubMed Web of Science ®Google Scholar
• Horn-Ross P L, John E M, Canchola A J, Stewart S L, Lee M M. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003; 95: 1158–1164
   PubMed Web of Science ®Google Scholar
• Zeleniuc-Jacquotte A, Lundin E, Micheli A, Koenig K L, Lenner P, Muti P, Shore R E, Johansson I, Krogh V, Lukanova A, Stattin P, Afansyeva Y, Rinaldi S, Arslan A A, Kaaks R, Berrino F, Hallmans G, Toniolo P, Adlercreutz H. Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006; 119: 2376–2381
   Google Scholar
• Lapidus L, Lindstedt G P.-A. L, Bengtson C, Gredmark T. Concentrations of sec-hormlone-binding globulin and corticosteroid-binding globulin in serum in relation to cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 1986; 31: 146–152
   Google Scholar
• Hämäläinen E, Tikkanen H, Härkönen M, Näveri H, Adlercreutz H. Serum lipoproteins, sex hormones and sex hormone binding globulin in middle aged men of different physical fitness and risk of coronary heart disease. Atherosclerosis 1987; 67: 155–162
   PubMedGoogle Scholar
• Hämäläinen E, Adlercreutz H, Ehnholm C, Puska P. Relationship of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. Metabolism 1986; 35: 535–541
   PubMed Web of Science ®Google Scholar
• Khaw K T, Barrett-Connor E. Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol 1987; 126: 1093–1102
   PubMed Web of Science ®Google Scholar
• Rimm E B, Ascherio A, Giovannucci E, Spiegelman D, Stampfer M J, Willett W C. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 275: 447–451
   PubMed Web of Science ®Google Scholar
• Pietinen P, Rimm E B, Korhonen P, Hartman A M, Willett W C, Albanes D, Virtamo J. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the alpha-tocopherol, beta-carotene cancer prevention study. Circulation 1996; 94: 2720–2727
   PubMed Web of Science ®Google Scholar
• Wolk A, Manson J E, Stampfer M J, Colditz G A, Hu F B, Speizer F E, Hennekens C H, Willett W C. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281: 1998–2004
   PubMed Web of Science ®Google Scholar
• Kushi L H, Lew R A, Stare F J, Ellison C R, El Lozy M, Bourke G, Daly L, Graham I, Hickey N R. M, Kevaney J. Diet and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 811–818
   PubMed Web of Science ®Google Scholar
• Jacobs D R, Jr., Meyer K A, Kushi L H, Folsom A R. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 1998; 68: 248–257
   PubMed Web of Science ®Google Scholar
• Liu S M, Stampfer M J, Hu F B, Giovannucci E, Rimm E, Manson J E, Hennekens C H, Willett W C. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999; 70: 412–419
   PubMed Web of Science ®Google Scholar
• Todd S, Woodward M, Tunstall Pedoe H, Bolton Smith C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol 1999; 150: 1073–1080
   PubMed Web of Science ®Google Scholar
• Erkkila A T, Herrington D M, Mozaffarian D, Lichtenstein A H. Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J 2005; 150: 94–101
   PubMed Web of Science ®Google Scholar
• Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts L J, Morrow J D, Adlercreutz H, Salonen J T. Association between low serum enterolactone and increased plasma F-2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 2002; 160: 465–469
   PubMedGoogle Scholar
• Kilkkinen A, Erlund I, Virtanen M J, Alfthan G, Ariniemi K, Virtamo J. Serum enterolactone concentration and risk of coronary heart disease in a case-control study of Finnish male smokers. Am J Epidem 2006; 163: 687–693
   Google Scholar
• Milder I EJ, Feskens E JM, Arts I CW, Bueno-de-Mesquita H B, Hollman P CH, Kromhout D. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen elderly study. Am J Clin Nutr 2006; 84: 400–405
   PubMed Web of Science ®Google Scholar
• van d er, Schouw Y T, Kreijkamp-Kaspers S, Peeters P HM, Keinan-Boker L, Rimm E B, Grobbee D E. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 2005; 111: 465–471
   Google Scholar
• Adlercreutz H, Fotsis T, Bannwart C, Hämäläinen E, Bloigu S, Ollus A. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Steroid Biochem 1986; 24: 289–296
   PubMedGoogle Scholar
• van d er, Schouw Y T, Sampson L, Willett W C, Rimm E B. The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in US men. J Nutr 2005; 135: 260–266
   Google Scholar
• van der Schouw Y T, Pijpe A, Lebrun C EI, Bots M L, Peeters P HM, van Staveren W A, Lamberts S WJ, Grobbee D E. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol 2002; 22: 1316–1322
   Google Scholar
• Bloedon L T, Szapary P O. Flaxseed and cardiovascular risk. Nutr Rev 2004; 62: 18–27
   PubMed Web of Science ®Google Scholar
• Linko-Parvinen A M, Landberg R, Tikkanen M J, Adlercreutz H, Penalvo J L. Alkylresorcinols from whole-grain wheat and rye are transported in human plasma lipoproteins. J Nutr 2007; 137: 1137–1142
   PubMed Web of Science ®Google Scholar
• Nurmi T, Voutilainen S, Nyyssonen K, Adlercreutz H, Salonen J T. Liquid chromatography method for plant and mammalian lignans in human urine. J Chromatogr B 2003; 798: 101–110
   PubMed Web of Science ®Google Scholar
• Wiseman H, O'Reilly J D, Adlercreutz H, Mallet A I, Bowey E A, Rowland I R, Sanders T AB. Isoflavone phytoestrogens consumed in soy decrease F-2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000; 72: 395–400
   PubMed Web of Science ®Google Scholar
• Dai Q, Franke A A, Jin F, Shu X O, Hebert J R, Custer L J, Cheng J R, Gan Y T, Zheng W. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidem Biomark Prev 2002; 11: 815–821
   PubMed Web of Science ®Google Scholar
• dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, McMichael A J, Sevak L. Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 2004; 15: 805–818
   PubMed Web of Science ®Google Scholar
• Fink B N, Steck S E, Wolff M S, Britton J A, Kabat G C, Schroeder J C, Teitelbaum S L, Neugut A I, Gammon M D. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 2007; 165: 514–523
   PubMed Web of Science ®Google Scholar
• Verheus M, van Gils C H, Keinan-Boker L, Grace P B, Bingham S A, Peeters P H. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007; 25: 648–655
   PubMed Web of Science ®Google Scholar